Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Mesothelioma, Malignant 5Hepatoblastoma 3Drug-Related Side Effects and Adverse Reactions 3Central Nervous System Neoplasms 3Ototoxicity 2Oligodendroglioma 2Neoplasms, Germ Cell and Embryonal 2Medulloblastoma 2Glioma 2Gastrointestinal Neoplasms 2Astrocytoma 2Thrombocytopenia 1Testicular Neoplasms 1Stomach Neoplasms 1Seminoma 1Sarcoma 1Rhabdomyosarcoma 1Rectal Neoplasms 1Peritoneal Neoplasms 1Pelvic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Mouth Neoplasms 1Mesothelioma 1Lymphoma 1Liver Neoplasms 1Liposarcoma 1

Interventions

Cisplatin 8Etoposide 7Carboplatin 7Paclitaxel 6Ifosfamide 6Filgrastim 4pegfilgrastim 2Therapeutics 2Radiotherapy 2Platinum 2Granulocyte Colony-Stimulating Factor 2Bleomycin 2tremelimumab 1sodium thiosulfate 1liposomal amphotericin B 1etoposide phosphate 1durvalumab 1cabozantinib 1Vinblastine 1Thiotepa 1Sunitinib 1Ribavirin 1Psychiatric Rehabilitation 1Peripheral Blood Stem Cell Transplantation 1Palivizumab 1Neoadjuvant Therapy 1Mesna 1Magnetic Resonance Spectroscopy 1Lenograstim 1Itraconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Seminoma × sodium thiosulfate × Clear all
NCT07218913 2026-04-17

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

City of Hope Medical Center

Phase 1 Recruiting
44 enrolled
Genitourinary

Testicular Neoplasms, Seminoma, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡